Early-stage returns?

Article Abstract:

The poor returns from investments on early-stage life science technological firms had led biotech pundits and practitioners to assert that the early-stage venture model is broken or dead. Their pessimism is unwarranted as the life science sector is transitioning to a more mature business ecosystem, and three emerging themes, namely an investor-friendly supply of innovation, greater fundamental demand to support exits and more capital-efficient biotech models to create value, should support attractive early-stage investing returns going forward.

Economic aspects, Return on investment, Rate of return

---

The hardest hire: Today's chief medical officer

Article Abstract:

Biotech companies are demanding professional chief medical officers (CMOs) as they play a strategic role in the phase 4, or post-marketing monitoring, evaluation and risk management. CMO needs to have professional experience gathered from different players in the drug development industry, since he needs to understand the objectives of he key players in the field.

Executive changes & profiles, Evaluation, Officials and employees, Executive ability, Corporate officers

---

Doing business with the NIH

Article Abstract:

The US National Institutes of Health (NIH) offers a wide menu of options like new or invigorated activities in technical assistance, technology licensing and financial considerations that bioentrepreneurs can use in their product development efforts. The long list of resources that the NIH makes available to bioentrepreneurs is described.

Services information, Services, United States. National Institutes of Health

Similar abstracts:

• Abstracts: In marine one battle, Lockheed invades Sikorsky's home turf
• Abstracts: Why are we here? Inspired and humbled. Fighting talk
• Abstracts: Every little helps. The career that Ian built. Taste of success
• Abstracts: Calling all exceptional managers. The verge of insanity
• Abstracts: Open, transparent indie firms flourish. Be wary of freelance 'solution'. Healthcare PR firms chart healthy gains in '04 fees

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.